194 related articles for article (PubMed ID: 20668153)
1. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria.
Araki S; Haneda M; Koya D; Isshiki K; Kume S; Sugimoto T; Kawai H; Nishio Y; Kashiwagi A; Uzu T; Maegawa H
Diabetes Care; 2010 Aug; 33(8):1805-10. PubMed ID: 20668153
[TBL] [Abstract][Full Text] [Related]
2. Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria.
Katavetin P; Katavetin P; Susantitaphong P; Townamchai N; Tiranathanagul K; Tungsanga K; Eiam-Ong S
Diabetes Res Clin Pract; 2010 Aug; 89(2):e33-5. PubMed ID: 20542586
[TBL] [Abstract][Full Text] [Related]
3. Urinary type IV collagen levels in diabetes mellitus.
Sthaneshwar P; Chan SP
Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
[TBL] [Abstract][Full Text] [Related]
4. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.
Morita M; Uchigata Y; Hanai K; Ogawa Y; Iwamoto Y
Am J Kidney Dis; 2011 Dec; 58(6):915-20. PubMed ID: 21763044
[TBL] [Abstract][Full Text] [Related]
5. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
Tan Y; Yang Y; Zhang Z; Zhang X; Zhang Z; Liu Y
Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
[TBL] [Abstract][Full Text] [Related]
6. Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study.
Kishi F; Nagai K; Takamatsu N; Tominaga T; Tamaki M; Shibata E; Murakami T; Kishi S; Abe H; Koezuka Y; Minagawa N; Ichien G; Doi T
PLoS One; 2018; 13(4):e0195523. PubMed ID: 29624611
[TBL] [Abstract][Full Text] [Related]
7. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.
Tashiro K; Koyanagi I; Ohara I; Ito T; Saitoh A; Horikoshi S; Tomino Y
J Clin Lab Anal; 2004; 18(3):206-10. PubMed ID: 15103687
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy.
Watanabe H; Sanada H; Shigetomi S; Katoh T; Watanabe T
Nephron; 2000 Sep; 86(1):27-35. PubMed ID: 10971150
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A
Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K
Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101
[TBL] [Abstract][Full Text] [Related]
11. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
Tofte N; Lindhardt M; Adamova K; Bakker SJL; Beige J; Beulens JWJ; Birkenfeld AL; Currie G; Delles C; Dimos I; Francová L; Frimodt-Møller M; Girman P; Göke R; Havrdova T; Heerspink HJL; Kooy A; Laverman GD; Mischak H; Navis G; Nijpels G; Noutsou M; Ortiz A; Parvanova A; Persson F; Petrie JR; Ruggenenti PL; Rutters F; Rychlík I; Siwy J; Spasovski G; Speeckaert M; Trillini M; Zürbig P; von der Leyen H; Rossing P;
Lancet Diabetes Endocrinol; 2020 Apr; 8(4):301-312. PubMed ID: 32135136
[TBL] [Abstract][Full Text] [Related]
12. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.
Araki S; Haneda M; Koya D; Sugaya T; Isshiki K; Kume S; Kashiwagi A; Uzu T; Maegawa H
Diabetes Care; 2013 May; 36(5):1248-53. PubMed ID: 23223350
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
15. Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy.
Kim SS; Song SH; Kim IJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Care; 2013 Mar; 36(3):656-61. PubMed ID: 23093662
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
18. Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy.
Iijima T; Suzuki S; Sekizuka K; Hishiki T; Yagame M; Jinde K; Saotome N; Suzuki D; Sakai H; Tomino Y
J Clin Lab Anal; 1998; 12(6):378-82. PubMed ID: 9850190
[TBL] [Abstract][Full Text] [Related]
19. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associations of microalbuminuria in proteinuria-negative patients with type 2 diabetes in two regional hospitals in Cameroon: a cross-sectional study.
Efundem NT; Assob JCN; Feteh VF; Choukem SP
BMC Res Notes; 2017 Sep; 10(1):477. PubMed ID: 28899432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
